Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

Sellam, J, Rivière, E, Courties, A et al. (11 more authors) (2017) Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research and Therapy, 19. 11. ISSN 1478-6354

Metadata

Authors/Creators:
  • Sellam, J
  • Rivière, E
  • Courties, A
  • Rouzaire, P-O
  • Tolusso, B
  • Vital, EM
  • Emery, P
  • Ferraccioli, G
  • Soubrier, M
  • Ly, B
  • Hendel Chavez, H
  • Taoufik, Y
  • Dougados, M
  • Mariette, X
Copyright, Publisher and Additional Information: (c) 2017, the Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Dates:
  • Accepted: 6 January 2017
  • Published (online): 23 January 2017
  • Published: 23 January 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 09 May 2017 15:29
Last Modified: 05 Oct 2017 16:23
Status: Published
Publisher: BioMed Central
Identification Number: https://doi.org/10.1186/s13075-017-1221-4

Share / Export

Statistics